Check out the latest news from Cinclus Pharma
During Life Science Sweden's conference "Pharma Outsourcing", Kjell Andersson, CSO at Cinclus Pharma, was interviewed about our drug candidate linaprazan glurate, which is an acid secretion inhibitor, a so-called P-CAB.
Read more
The story of Cinclus Pharma started when a chemist, a pharmacologist, a gastroenterologist, and three experts in finance and business development came together to address the unmet medical need for reflux disease treatment.
Read more
Millions of people around the world suffer from Gastroesophageal reflux disease, GERD. Most people can relate to discomfort caused by reflux and heartburn, two of the most common symptoms caused by light versions of GERD.
Read more